PCa immunotherapy: Response better when given before ADT – ModernMedicine
|
PCa immunotherapy: Response better when given before ADT
ModernMedicine Administering sipuleucel-T (Provenge) before androgen deprivation therapy in men with hormone-sensitive biochemically recurrent prostate cancer appears to result in a more robust immunologic response than when the immunotherapy is given after … |
